CARDIOMEMS Intracardiac Continuous Cardiac Hemodynamic Monitoring Device
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CARDIOMEMS Intracardiac Continuous Cardiac Hemodynamic Monitoring Device, covering 2024-12-10 to 2024-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Tolerability and Safety of CARDIOMEMS™ Intracardiac Continuous Cardiac Hemodynamic Monitoring Device in Patients with Cardio Renal Syndrome with Severe Renal Impairment [NA]